Growth hormone receptor antagonism downregulates ATP-binding cassette transporters contributing to improved drug efficacy against melanoma and hepatocarcinoma in vivo.
Basu R, Qian Y, Mathes S, Terry J, Arnett N, Riddell T, Stevens A, Funk K, Bell S, Bokal Z, Batten C, Smith C, Mendez-Gibson I, Duran-Ortiz S, Lach G, Mora-Criollo PA, Kulkarni P, Davis E, Teaford E, Berryman DE, List EO, Neggers S, Kopchick JJ.
Basu R, et al. Among authors: riddell t.
Front Oncol. 2022 Jul 5;12:936145. doi: 10.3389/fonc.2022.936145. eCollection 2022.
Front Oncol. 2022.
PMID: 35865483
Free PMC article.